BRCA1 and neoplasm: The PRS based on SNPs associated with ER-negative disease in the general population displayed a much stronger association with overall breast cancer risk for BRCA1 carriers than the ER-positive PRS, consistent with the observation that the predominant tumor subtype in BRCA1 carriers is ER negative (34,35).